Eurartesim(R) (dihydroartemisinin piperaquine: DHA-PQP), the first artemisinin combination therapy (ACT) approved by the European Medicines Agency (EMA) for the treatment of uncomplicated malaria, is being prepared for roll-out in several countries. Eurartesim(R), was developed collaboratively by Sigma Tau Group, Italy, and the not-for-profit research foundation Medicines for Malaria Venture (MMV). The EMA-approved Eurartesim(R) is now ready for delivery to Cambodia, the first malaria endemic country to place an order for this newly approved treatment...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment